CNBC · Ian Thomas ·

Thyme Care, which focuses on filling cancer treatment gaps via a virtual navigation platform, raised a $125M Series E at a $2B+ valuation, up from $1B+ in 2025

Despite recent advancements in oncology, the branch of medicine focused on the study, prevention, diagnosis and treatment of cancer …

Venture Capital

In this story Thyme Care

Thyme Care, which focuses on filling cancer treatment gaps via a virtual navigation platform, raised a $125M Series E at a $2B+ valuation, up from $1B+ in 2025

Lead Source

CNBC — Thyme Care, which focuses on filling cancer treatment gaps via a virtual navigation platform, raised a $125M Series E at a $2B+ valuation, up from $1B+ in 2025 ↗

How this story grew

Coverage · 0 Discussion · 0

Sep 2Sep 3

More

Thyme Care: Thyme Care

RuntimeWire: RuntimeWire

Nashville Business Journal: Nashville Business Journal

MedCity News: MedCity News

Pulse 2.0: Pulse 2.0

Discussion

Etan Raskas Jessa Kelley Robin Shah Dan Mendelson

Related stories

Bloomberg: Forus, which uses AI to help patients get prescribed drugs more quickly by navigating steps like insurance coverage, raised a $150M Series C at a $3B valuation

Business Insider: Devoted Health, which uses AI to help coordinate medical care for those enrolled in Medicare Advantage, is raising new funding at a $25B valuation

MobiHealthNews: Scan.com, which uses AI to match patient referrals with imaging centers by availability, price, and specialty, raised a $220M Series C, including $90M in equity

New York Times: Thrive Capital's Thrive Holdings, which acquires traditional service businesses and adds AI, raised $2B from SoftBank, D1, and others at a $12B valuation

Upstarts Media: AI CRM software startup Lightfield raised a $47M Series A led by a16z; formerly Tome, it had raised $80M across earlier Series A and B rounds

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif